Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

CINCINNATI, July 15, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. ("Onconetix" or the "Company") (Nasdaq: ONCO), today announced the closing of the previously announced exercise of certain existing warrants to purchase 7,458,642 shares of its common stock having exercise prices ranging from $1.09 to$2.546 per share, at a reduced exercise price of $0.15 per share. The aggregate gross proceeds from the exercise of the existing warrants were approximately$1.11 million, before deducting placement agent fees and o ...